Keywords
deep vein thrombosis, direct-acting oral anticoagulants, direct oral anticoagulants, DOACs, drug-drug interactions, DVT, periprocedural management, phase of treatment, provoked VTE, reversal strategies, thromboembolic risk factors, unprovoked VTE, venous thromboembolism, VTE